Did you know—30 million doses of the Oxford-AstraZeneca are sitting idle in the US, awaiting results from its U.S. clinical trial while countries that have authorized its use beg for access. That is 30 million doses sitting idle in Ohio factory! #COVID19 nytimes.com/2021/03/11/us/…
2) “Emergent BioSolutions, a company in Maryland that AstraZeneca has contracted to manufacture its vaccine in the United States, has also produced enough vaccine in Baltimore for tens of millions more doses once it is filled into vials and packaged, the official said.
3) “But although AstraZeneca’s vaccine is already authorized in more than 70 countries, according to a company spokesman, its U.S. clinical trial has not yet reported results, and the company has not applied to the Food and Drug Administration for emergency use authorization.
4) “AstraZeneca has asked the Biden administration to let it loan American doses to the EU, where it has fallen short of its original supply commitments and where the vaccination campaign has stumbled badly. The administration, for now, has denied the request, one official said.
5) I’m aware of a group being formed to help LMIC countries get vaccine access in addition to CoVAX. Im hopeful of these new initiatives. But we need vaccine access faster and sooner rather than later. Time is of the essence.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
